The understanding of the impact of the CD137-CD137L axis is incomplete if manipulation on the CD137L signalling is not investigated since immune deviation and subsequent phenotypic alterations are unpredictable if CD137L signalling is altered in SLE. This evidence concerns the gene TNFRSF9 and systemic lupus erythematosus.